Compare ODFL & BDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ODFL | BDX |
|---|---|---|
| Founded | 1934 | 1897 |
| Country | United States | United States |
| Employees | 20591 | N/A |
| Industry | Trucking Freight/Courier Services | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 43.8B | 51.5B |
| IPO Year | 1996 | 1996 |
| Metric | ODFL | BDX |
|---|---|---|
| Price | $209.90 | $147.18 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 21 | 13 |
| Target Price | ★ $190.15 | $186.00 |
| AVG Volume (30 Days) | 1.9M | ★ 2.9M |
| Earning Date | 04-29-2026 | 05-07-2026 |
| Dividend Yield | 0.55% | ★ 2.89% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.14 | 0.25 |
| Revenue | $5,496,389,000.00 | ★ $21,840,000,000.00 |
| Revenue This Year | $4.41 | N/A |
| Revenue Next Year | $9.04 | $3.02 |
| P/E Ratio | ★ $181.75 | $585.62 |
| Revenue Growth | N/A | ★ 8.24 |
| 52 Week Low | $126.01 | $141.82 |
| 52 Week High | $233.79 | $213.08 |
| Indicator | ODFL | BDX |
|---|---|---|
| Relative Strength Index (RSI) | 56.28 | 46.76 |
| Support Level | $187.36 | N/A |
| Resistance Level | $221.63 | $158.66 |
| Average True Range (ATR) | 6.80 | 4.48 |
| MACD | 1.05 | 0.60 |
| Stochastic Oscillator | 96.32 | 39.86 |
Old Dominion Freight Line is the second-largest less-than-truckload carrier in the United States (following FedEx Freight), with roughly 260 service centers and 11,000-plus tractors. It is one of the most disciplined and efficient providers in the trucking industry, and its profitability and capital returns are well above those of its peers. Strategic initiatives focus on increasing network density through market-share gains and on maintaining industry-leading service (including ultralow cargo claims) through steadfast infrastructure investment.
Becton Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments, and reagents, as well as flow cytometry and cell-imaging systems. On a 2025 sales basis, following the spinoff, BD Medical Essentials represented 34% of revenue, the Interventional segment 28%, Connected Care 25%, and Biopharma 13%. International revenue accounts for 43% of the company's business.